BMS-1166, PD-1/PD-L1 inhibitor (TBI4903)
Price range: $117.00 through $342.00
PD-1/PD-L1 inhibitor
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBI4903-1MG | Yes | 1 MG | $117.00 | |||
| TBI4903-5MG | Yes | 5 MG | $342.00 |
- Description
- Terms
- Additional information
- Documents
- Reviews (0)
Description
Product Details
Formal Name: (2R,4R)-1-[[5-Chloro-2-[(3-cyanophenyl)methoxy]-4-[[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-methylphenyl]methoxy]phenyl]methyl]-4-hydroxypyrrolidine-2-carboxylic acid
Molecular Formula: C36H33ClN2O7
Formula Weight: 641.1
CAS Number: 1818314-88-3
Purity: >98%
Formulation: Powder
Solubility: Soluble in DMSO (up to at least 25 mg/ml)
Storage: -20°C
Stability: ≥ 1 year.
Applications
PD-1/PD-L1 inhibitor
Functions
Blocks the cell surface interaction of PD-L1 with PD-1 alleviating the inhibitory effect of PD-L1 on T-cell receptor-mediated activation of T-lymphocytes (IC50 = 1.4 nM). It suppressed growth and invasion of glioma cells and induced apoptosis in conjunction with the dual PI3K/mTOR inhibitor BEZ235. BMS-1166 reversed HEL-mediated T cell suppression in acute myeloid leukemia patients. It significantly decreased cell viability and enhanced chemotherapy-induced cytotoxicity in MDF-MB-231 and MCF-7 breast cancer models.
Application Procedures
First dissolved in DMSO (up to at least 25 mg/ml), then diluted to aqueous buffer. Solutions in DMSO may be stored at -20°C for up to 3 months.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 5 MG |
|---|
Be the first to review “BMS-1166, PD-1/PD-L1 inhibitor (TBI4903)”
You must be logged in to post a review.












Reviews
There are no reviews yet.